⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12028061 | 0.75 | — | — | |
| SCHEMBL8658 | 0.67 | — | — | |
| SCHEMBL2500362 | 0.61 | — | — | |
| SCHEMBL12028059 | 0.61 | — | — | |
| SCHEMBL12028098 | 0.59 | — | — | |
| SCHEMBL18653951 | 0.57 | — | — | |
| SCHEMBL22562861 | 0.57 | — | — | |
| SCHEMBL29221443 | 0.57 | — | — | |
| SCHEMBL9472 | 0.54 | — | — | |
| SCHEMBL12028057 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598586-A1 | DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF | Ambrx, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| WO-2024241086-A1 | PEGYLATED BOVINE INTERFERON LAMBDA AND METHODS OF USE THEREOF | AMBRX, INC. (US) | 2024-11-28 | — | — | WO | claimed |
| WO-2024215515-A1 | DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF | AMBRX, INC. (US) | 2024-10-17 | — | — | WO | claimed |
| WO-2024178310-A1 | TROP2-DIRECTED ANTIBODY-DRUG CONJUGATES AND USES THEREOF | AMBRX, INC. (US) | 2024-08-29 | — | — | WO | claimed |
| WO-2024178360-A2 | AURISTATIN ANALOGS AND ANTIBODY CONJUGATES THEREOF | AMBRX, INC. (US) | 2024-08-29 | — | — | WO | claimed |
| WO-2024077277-A1 | DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF | AMBRX, INC. (US) | 2024-04-11 | — | — | WO | claimed |
| US-20230313180-A1 | MULTIMERIC ANTIBODY PLATFORM AND METHODS OF MAKING AND USING MULTIMERIC ANTIBODY PLATFORM | OREGON STATE UNIVERSITY (US) | 2023-10-05 | — | — | US | claimed |
| CN-115417821-A | Substituted 1, 4-dihydropyridazine derivative and preparation and application thereof | 湖北科技学院 | 2022-12-02 | — | — | CN | claimed |
| US-10851192-B2 | Dihydropyridazine-based antioxidants and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2020-12-01 | — | — | US | claimed |
| CN-111848526-A | Polysubstituted 1, 4-dihydropyridazine and pyridazine derivatives and synthetic method thereof | 南京工业大学 | 2020-10-30 | — | — | CN | claimed |
| WO-2003099284-A1 | AMINO-PYRIDINE, -PYRIDINE AND PYRIDAZINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN | AMGEN INC. (US) | 2003-12-04 | — | — | WO | claimed |
| US-20030195201-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN INC. | 2003-10-16 | — | — | US | claimed |
| WO-2003049702-A2 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS | AMGEN INC. (US) | 2003-06-19 | — | — | WO | claimed |
| EP-0173205-A2 | 1,4-Dihydropyridazine derivatives, process for their preparation and their use in medicaments | BAYER AG (DE) | 1986-03-05 | — | — | EP | claimed |
| US-4348395-A | 1,4-Dihydropyridazine compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1982-09-07 | — | — | US | claimed |
| EP-0001108-B1 | 1,4-DIHYDROPYRIDAZINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICALS | BAYER AG (DE) | 1981-04-29 | — | — | EP | claimed |
| EP-0001439-B1 | 1-N-SUBSTITUTED 1.4-DIHYDROPYRIDAZINE DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE FOR PHARMACEUTICALS | BAYER AG (DE) | 1981-01-28 | — | — | EP | claimed |
| EP-0001439-A1 | 1-N-substituted 1.4-dihydropyridazine derivatives, method for their preparation and their use for pharmaceuticals | BAYER AG (DE) | 1979-04-18 | — | — | EP | claimed |
| EP-0001108-A1 | 1,4-Dihydropyridazines, process for their preparation and their use in pharmaceuticals | BAYER AG (DE) | 1979-03-21 | — | — | EP | claimed |
| US-4008239-A | Preparation of 4-(3-nitrophenyl)pyridine | STERLING DRUG INC. (US) | 1977-02-15 | — | — | US | claimed |